J. Rossler et al., Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia, INT J CANC, 81(1), 1999, pp. 113-117
Enhanced angiogenesis apparently contributes to the poor clinical outcome o
f human neuroblastoma, but the mechanisms have remained unclear. We report
here that cultured human neuroblastoma cells express a bioactive endothelia
l cell growth factor indistinguishable from the angiogenesis stimulator vas
cular endothelial growth factor (VEGF). VEGF is present in neuroblastoma bu
t not vascular endothelial cells, whereas the corresponding VEGF receptors
(Flt-1 and Flk-1/ KDR) are expressed in endothelial but not neuroblastoma c
ells. Exposure of neuroblastoma cells to hypoxia induces a marked increase
in bioactive VEGF. VEGF is also present in human neuroblastoma specimens, w
ith substantial amounts in apparently hypoxic neuroblastoma cells, eventual
ly accumulating in tumor microvessels. Our results indicate that VEGF (i) i
s present in human neuroblastomas, (ii) is up-regulated by tumor hypoxia an
d (iii) may stimulate neuroblastoma angiogenesis by paracrine mechanisms, t
hereby contributing to the progression of human neuroblastomas. We suggest
that inhibition of VEGF activity may represent a novel approach for the the
rapy of human neuroblastoma. (C) 1999 Wiley-Liss, Inc.